ResearcherSanford Burnham Prebys Medical Discovery InstituteActive in the last 2 years

Nathan L. Tran

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7917-3945; OpenAlex author ID A5036682403. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC. Co-author DOI 10.1038/s41589-025-01978-1 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kevin Christian Montecillo Gulay · 1 shared paper, 2026 · strength 0.24
- Paper ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC. DOI 10.1038/s41589-025-01978-1 ↗
Fleur M. Ferguson · 1 shared paper, 2026 · strength 0.24
- Paper ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC. DOI 10.1038/s41589-025-01978-1 ↗
Andrew M. Lowy · 1 shared paper, 2026 · strength 0.24
- Paper ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC. DOI 10.1038/s41589-025-01978-1 ↗
Hervé Tiriac · 1 shared paper, 2026 · strength 0.24
- Paper ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC. DOI 10.1038/s41589-025-01978-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.